Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.
J J KimDonghee KimJ Y YimJ H KangK H HanS M KimK R HwangS Y KuC S SuhS H KimY M ChoiPublished in: Alimentary pharmacology & therapeutics (2017)
Non-obese NAFLD is more prevalent in women with polycystic ovary syndrome than in those without. In non-obese patients with polycystic ovary syndrome, hyperandrogenemia may be an independent risk factor for non-obese NAFLD.